Gas-conserving regulators include oxygen regulators, which are used to supply a patient with a regulated flow of oxygen. The oxygen is supplied by a source of compressed oxygen, such as from a supply tank, which has its pressure reduced to a low pressure for delivery to the patient. Typical oxygen regulators employ a back-pressure piston to supply a continuous flow of that low pressure oxygen to the patient. Much of that oxygen is wasted because it is not inhaled by the patient.
To reduce the amount of wasted oxygen, oxygen-conserving regulators have been developed which tend to limit the oxygen flow to periods of inhalation. One way of controlling the oxygen flow is by electronic means. In a typical electronic conserver, a solenoid valve controls the flow of oxygen to the patient. The solenoid valve can accurately open to provide the flow of oxygen to the patient when the patient inhales, and close between breaths. Typically, the solenoid valve requires large energy requirements so that a C or D sized battery powering the solenoid valve might last only one month.
Embodiments of the present invention include a gas conserving regulator which can deliver gas to a patient with the accuracy of an electronic conserver, but with significantly reduced energy consumption so that batteries can last much longer or can be smaller.
One embodiment includes a gas regulator including a slave valve assembly for receiving and controlling the flow of gas to a desired destination. A timing chamber can be positioned adjacent to the slave valve assembly. The timing chamber has an inlet for also receiving the gas. An electronically operated pilot valve assembly can be in communication with the timing chamber for operating the slave valve assembly. When the pilot valve assembly is closed, gas pressure within the timing chamber acting on the slave valve assembly closes the slave valve assembly. When the pilot valve assembly is open, gas exits the timing chamber and reduces the gas pressure in the timing chamber, thereby allowing the slave valve assembly to open and deliver the gas to the desired destination.
In particular embodiments, the gas is oxygen which is delivered to a patient. A sensing circuit can sense inhalation by the patient for controlling the electronically operated pilot valve assembly.
The slave valve assembly can include a slave valve nozzle and a slave valve member for engaging the slave valve nozzle. The gas pressure within the timing chamber acting on the slave valve member can control the operation of the slave valve member, which can be a diaphragm.
In one embodiment, the electronically operated pilot valve assembly can include a piezoelectric device. In another embodiment, the electronically operated pilot valve assembly can be a solenoid operated pilot valve assembly.
The solenoid operated pilot valve assembly can include a pilot valve nozzle and a pilot valve member for engaging the pilot valve nozzle. A solenoid operates the pilot valve member. A spring can be used to bias the pilot valve member towards the pilot valve nozzle to be normally closed. The pilot valve nozzle and the pilot valve member can be aligned along a common axis whereby the pilot valve member moves along the axis for engaging and disengaging from the pilot valve nozzle.
The timing chamber and the solenoid operated pilot valve assembly can be positioned within a common housing with the timing chamber and the pilot valve nozzle being connected by a passage therebetween. The slave and pilot valve nozzles each have an opening where the pilot valve nozzle opening can be smaller than the slave valve nozzle opening for minimizing the solenoid size and energy expended by the solenoid. The slave and pilot valve nozzle openings can be sized to provide at least about a 45:1 area and solenoid energy efficiency ratio. For such a ratio, the slave valve nozzle opening can be at least about 0.048 inches in diameter and the pilot valve nozzle opening can be about 0.007 inches in diameter.
The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of particular embodiments of the invention, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.
In electronic conservers, the opening of the nozzle 16 must be large enough to deliver the required amount of oxygen to the patient during the actuation period. For a system operating at a normal pressure of 15-25 PSI, the nozzle 16 typically has an opening that is about 3/64 inches in diameter. The solenoid valve 18 must therefore be able to seal the nozzle 16 against the gas pressure. At 22 PSI, for example, the solenoid 14 must provide at least about 0.04 pounds of resistance to seal the nozzle 16. That requires a fairly large solenoid unit, which has significant energy requirements. To meet those energy requirements, typical prior art conservers use a C or D-size battery. That battery is the largest single component of prior art conservers. Such batteries may only last for about one month.
Conserver 20 includes a housing 20a having a slave valve assembly 40 which receives low pressure oxygen from a pressure regulating portion 19. The pressure regulating portion 19 is in communication with a pressurized source of oxygen, such as from a supply tank which is often at about 2200 psi. The pressure regulating portion 19 typically includes a back pressure piston assembly, as is common in the art, which reduces the pressure of oxygen received from the pressurized source to between about 15-25 psi, typically about 22 psi. The slave valve assembly 40 controls the flow of the low pressure oxygen to the patient through a passage 50 and, in turn, is controlled by a solenoid operated pilot valve assembly 30. The slave valve assembly 40 is sized to deliver a sufficient amount of oxygen to the patient while the solenoid operated pilot valve assembly 30 is designed to use a minimal amount of energy while at the same time being capable of controlling the slave valve assembly 40. Typically, tubing is connected in communication with passage 50 and connected to the patient for delivering the oxygen through a mask or cannula.
The slave valve assembly 40 includes a slave valve nozzle 42 with a nozzle opening 46 and a filter 48 which receives oxygen from the pressure regulating portion 19. A slave valve member 44, typically a diaphragm, is engageable with the slave valve nozzle 42 for opening and closing the slave valve assembly 40. The operation of the slave valve member 44 is determined by the pressure within a timing chamber 54 adjacent to or against the slave valve member 44 which receives low pressure oxygen through an inlet passage 52. The timing chamber 54 is in communication with the solenoid operated pilot valve assembly 30 through a passage 38 in the housing 20a. The opening and closing of the pilot valve assembly 30 controls the pressure within timing chamber 54 and, therefore, the operation of the slave valve assembly 40.
The solenoid operated pilot valve assembly 30 has a pilot valve nozzle 32 and a pilot valve member 26 for engaging the pilot valve nozzle 32. The pilot valve member 26 is biased by a spring 24 against the pilot valve nozzle 32 to be normally closed and is opened by the activation of a solenoid 28. The pilot valve member 26 has a sealing surface or member 22 for sealing the pilot valve nozzle 32. The pilot valve assembly 30 is positioned in a cavity 34 within the housing 20a with the pilot valve nozzle 32 and the pilot valve member 26 extending into the cavity 34 from opposite sides. The cavity 34 is in communication with the atmosphere through a passage 36.
The solenoid 28 is controlled by a sensing circuit 64 which senses inhalation of the patient. The sensing circuit 64 includes a controller 58 that is connected to the solenoid 28 via line 56, and a sensor 62 which is in communication with controller 58 via line 60. The sensor 60 is positioned in a location to sense inhalation of the patient, such as in communication with the tubing connected to the patient.
In operation, referring to
Referring to
Referring to
A more detailed discussion of embodiments of conserver 20 now follows. The conserver 20 is typically operated with a single-lumen cannula, but alternatively can be operated with a dual-lumen cannula. The diaphragm of the slave valve member 44 forms one of the boundaries of the timing chamber 54 as well as operates as a valve member. The slave valve member 44 typically requires gas pressure in order to be closed. When there is no gas pressure, the slave valve member 44 can be apart from the slave valve nozzle 42. The sealing member 22 on the pilot valve member 26 is typically made of polymeric material suitable for sealing pilot valve nozzle 32, such as silicone rubber, or similar materials. In the embodiment shown in
In comparison to the pilot valve nozzle 32, the nozzle opening in a conventional electronic conserver is typically about 3/64 inches in diameter for providing sufficient oxygen flow to the patient so that the force exerted by the gas at a pressure of 22 psi within such an opening against a valve member is about 0.04 lbs. and is over 45 times greater than in the opening 32a that is about 0.007 inches in diameter, because the ratio of the area of the nozzle openings is about 45:1. As a result, it can be seen that the solenoid 28 in conserver 20 can be sized many times smaller than the solenoid in a conventional electronic conserver. With the solenoid 28 being sized smaller than those in conventional electronic conservers, less energy is required for operation.
The solenoid energy efficiency can be directly proportional to the ratio of forces entered through the opening 32a in the pilot valve nozzle 32 relative to the opening in a standard electronic conserver. In embodiments having a pilot valve nozzle 32 with an opening 32a about 0.007 inches in diameter, the conserver 20 can have about a 45:1 solenoid efficiency ratio relative to a standard electronic conserver. That is, the solenoid 28 in the conserver 20 is about 45 times more energy efficient than a solenoid in a standard electronic conserver.
This means that a battery, that may only operate for one month in a conventional electronic conserver, can operate the conserver 20 for nearly four years. It also follows that a smaller battery, such as a camera battery, can be used to power the conserver 20 for an adequate period of time. Such advantages permit the conserver 20 to be both smaller and lighter than the conventional electronic conservers.
The conserver 20 allows for a variety of conserving ratios, defined as the ratio of the volume of oxygen delivered to the patient in comparison with the volume delivered by a standard, non-conserving regulator operating at the same flow rate. The conserver 20 can also be operated with a continuous, non-conserving flow at all flow settings, unlike conventional single-lumen conservers, most of which have only one continuous flow setting.
There are a number of variations that can be made to the mechanism with regard to the deactivation of the solenoid 28. In one such variation, the pilot valve member 26 can remain open for a fixed amount of time. To vary the amount of oxygen delivered to the patient, the flow rate of the oxygen can be adjusted. In another variation, the conserver 20 can deliver oxygen at a fixed flow rate, while the pilot valve member 26 remains open for a variable amount of time. This also allows the user to vary the amount of oxygen delivered to the patient. In yet another variation, the pilot valve member 26 can be opened using electronic means, and a pneumatic timer can be used to close the pilot valve member 26.
In another embodiment, the solenoid-controlled pilot valve member 26 can be replaced by a piezoelectric device. Circuitry can excite the piezo device, causing the piezo device to open the pilot valve nozzle, such as by expanding.
While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
For example, although conserver 20 has been described for delivering oxygen to a patient, it is understood that conserver 20 can be used to deliver other gases, and to other desired destinations. Other therapeutic gases can be delivered such as nitrous oxide, or non-therapeutic gas can be delivered, such as lethal gases or gases for industrial uses. Although the components of the slave valve assembly 40 and the solenoid operated pilot valve assembly 30 have been shown in the figures to be aligned along axis A, alternatively, these components do not have to be in alignment with each other. In addition, it is understood that the slave valve assembly 40 and the solenoid operated pilot valve assembly 30 can have configurations other than those shown and described. For example, in some embodiments, the slave valve member can be a rigid member such as a piston having a large surface area acted on by gas pressure in the timing chamber 54 and a small surface area acted on by gas pressure in the nozzle opening 46. Also, gate valve configurations are possible. Other embodiments of the conserver 20 can have a solenoid operated pilot valve assembly including a spool that is shifted laterally relative to the gas flow for opening and closing the pilot valve assembly. Also, the solenoid operated pilot valve assembly can be located in a different housing than the slave valve assembly 40. Furthermore, it is understood that the diameter of the opening 32a of the pilot valve nozzle 32 can be varied to obtain the desired combination of energy efficiency and venting speed of timing chamber 55. Finally, it is understood that features of the present invention can be omitted or combined.
This application claims the benefit of U.S. Provisional Application No. 60/444,995, filed Feb. 4, 2003. The entire teachings of the above application are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4736750 | Valdespino et al. | Apr 1988 | A |
4738283 | Shirai et al. | Apr 1988 | A |
4789143 | Smith et al. | Dec 1988 | A |
4932402 | Snook et al. | Jun 1990 | A |
5038774 | Chabert | Aug 1991 | A |
5479920 | Piper et al. | Jan 1996 | A |
6036445 | Reynolds | Mar 2000 | A |
6116242 | Frye et al. | Sep 2000 | A |
6170526 | O'Neill | Jan 2001 | B1 |
6364161 | Pryor | Apr 2002 | B1 |
6427967 | Evans | Aug 2002 | B1 |
6793199 | Bushik et al. | Sep 2004 | B2 |
20040154693 | Zaiser et al. | Aug 2004 | A1 |
Number | Date | Country | |
---|---|---|---|
20050039752 A1 | Feb 2005 | US |
Number | Date | Country | |
---|---|---|---|
60444995 | Feb 2003 | US |